As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback